Cambridge Investment Research Advisors, Inc. - CNS PHARMACEUTICALS INC ownership

CNS PHARMACEUTICALS INC's ticker is CNSP and the CUSIP is 18978H102. A total of 21 filers reported holding CNS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of CNS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$5,000
-28.6%
25,2500.0%0.00%
Q2 2022$7,000
-22.2%
25,2500.0%0.00%
Q1 2022$9,000
-50.0%
25,2500.0%0.00%
Q4 2021$18,000
+5.9%
25,250
+124.4%
0.00%
Q3 2021$17,000
-15.0%
11,250
+9.8%
0.00%
Q2 2021$20,00010,2500.00%
Other shareholders
CNS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Altium Capital Management LP 534,148$951,0000.36%
CVI Holdings, LLC 415,652$740,0000.14%
ESSEX INVESTMENT MANAGEMENT CO LLC 61,307$109,0000.01%
Warberg Asset Management LLC 14,000$25,0000.01%
Alpha Cubed Investments, LLC 10,000$18,0000.00%
Integrated Advisors Network LLC 10,700$19,0000.00%
Core Wealth Advisors, Inc. 550$1,0000.00%
OSAIC HOLDINGS, INC. 5,000$9,0000.00%
WELLS FARGO & COMPANY/MN 41$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CNS PHARMACEUTICALS INC shareholders